← SynDRA
TROXIPIDE
SynDRA canonical compound SYN0025572 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | glucosamine synthetase stimulant |
|---|
| Indication | gastroesophageal reflux disease (GERD) |
|---|
| Disease area | gastroenterology |
|---|
Mechanisms of action (all sources)
- glucosamine synthetase stimulant
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- NPY1R
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- GHSR
- MMP9
- NPY2R
- FLT1
- NR1I2
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SIGMAR1
- PTPRC
- PTGS2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ATC classes
- A02B · DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Cross-references
Synonyms
- aplace
- KU-54
- Troxipida
- Aplace
- 3,4,5-trimethoxy-N-(piperidin-3-yl)benzamide
- Troxipidum
- W6QJX1Q00Z
- 3-(3,4,5-Trimethoxybenzamido)piperidine
- DTXCID303725
- RefChem:900675
- A02BX11
- 3,4,5-Trimethoxy-N-((3RS)-piperidin-3-yl)benzamide
- Benzamide, 3,4,5-trimethoxy-N-3-piperidinyl-
- 3,4,5-Trimethoxy-N-(3-piperidyl)benzamide
- 3,4,5-trimethoxy-n-piperidin-3-ylbenzamide
- MFCD00866876
- NCGC00183029-01
- Troxipidum [Latin]
- Troxipida [Spanish]
- Troxipide [INN:JAN]
- SMR000466385
- CAS-30751-05-4
- UNII-W6QJX1Q00Z
- BRN 0493078
- Aplace (TN)
- Troxipide (Standard)
- TROXIPIDE [INN]
- TROXIPIDE [JAN]
- TROXIPIDE [MI]
- Troxipide (JP18/INN)
- TROXIPIDE [MART.]
- TROXIPIDE [WHO-DD]
- (+-)-3,4,5-Trimethoxy-N-3-piperidylbenzamide
- Benzamide, N-(3-piperidyl)-3,4,5-trimethoxy-
- 5-22-08-00030 (Beilstein Handbook Reference)
- MLS000759522
- MLS001424037
- SCHEMBL400623
Look up TROXIPIDE in the interactive SynDRA portal →